Evidence map›Paper›PMID 22198733›Full record

ArticleNature chemical biology2011

Small-molecule proteostasis regulators for protein conformational diseases.

Barbara Calamini, Maria Catarina Silva, Franck Madoux, Darren M Hutt, Shilpi Khanna, Monica A Chalfant, S Adrian Saldanha, Peter Hodder, Bradley D Tait, Dan Garza and 2 more

Abstract read
In one paragraph

Article in Nature chemical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 225 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Role of NRF2 in Trinucleotide Repeat Expansion Disorders.Antioxidants (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Article
  12. HSF1 and Its Role in Huntington's Disease Pathology.Advances in experimental medicine and biology · 2023
    Review
  13. Frontiers in cell and developmental biology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Covalent sortase A inhibitor ML346 preventsRSC medicinal chemistry · 2022
    Article
  18. Article
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Barbara CalaminiDepartment of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, Evanston, Illinois, USA.
Maria Catarina Silva
Franck Madoux
Darren M Hutt
Shilpi Khanna
Monica A Chalfant
S Adrian Saldanha
Peter Hodder
Bradley D Tait
Dan Garza
William E Balch
Richard I Morimoto
Scripps Research Institute · USProteostasis Therapeutics (United States) · USRice Institute · US

Funding

UHTS Implementation(Florida)U54MH084512 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI DING, SHENG · 2008 to 2013
$89.2M
Modulation of Lung Disease by Genetic/Epigenetic ProfilingR01HL095524 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI William Edward Balch · 2010 to 2026
$7.5M
TRAINING PROGRAM IN SIGNAL TRANSDUCTION AND CANCERT32CA070085 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1997 to 2026
$5.7M
REGULATION AND EXPRESSION OF THE HSP70 GENE FAMILYR37GM038109 · NIGMS · NORTHWESTERN UNIVERSITY · PI MORIMOTO, RICHARD I · 2000 to 2009
$5.6M
ROLE OF RAB PROTEINS AND CA2+ IN VESICULAR TRANSPORTR01GM042336 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BALCH, WILLIAM EDWARD · 1990 to 2011
$4.8M
Structure and Function of Guanine Nucleotide Dissociation InhibitorR01GM033301 · NIGMS · YALE UNIVERSITY · PI BALCH, WILLIAM EDWARD · 1985 to 2012
$4.6M
Proteomic Profiling of CFTR Protein InteractionR01HL079442 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI BALCH, WILLIAM EDWARD, YATES III, JOHN R · 2005 to 2014
$4.6M
C. elegans Model for Neurodegenerative Diseases of AgingR37AG026647 · NIA · NORTHWESTERN UNIVERSITY · PI MORIMOTO, RICHARD I · 2010 to 2019
$3.9M
DRUG DISCOVERY TRAINING IN AGE-RELATED DISORDERST32AG000260 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WATTERSON, DANIEL MARTIN · 1998 to 2010
$2.7M
REGULATION AND EXPRESSION OF THE HUMAN HSP70 GENE FAMILYR01GM038109 · NIGMS · NORTHWESTERN UNIVERSITY · PI MORIMOTO, RICHARD I · 1987 to 2013
$2.2M
C. Elegans Model for Neurodegenerative Diseases of AgingR01AG026647 · NIA · NORTHWESTERN UNIVERSITY · PI MORIMOTO, RICHARD I · 2005 to 2009
$2.0M
Celestrols for Treatment of Neurodegenerative DiseasesR01NS047331 · NINDS · NORTHWESTERN UNIVERSITY · PI SILVERMAN, RICHARD B · 2004 to 2007
$1.2M
CIHRNCI NIH HHS T32 CA070085NCI NIH HHS T32 CA70085NHLBI NIH HHS HL 079442NHLBI NIH HHS R01 HL079442NHLBI NIH HHS R01 HL095524NIA NIH HHS AG026647NIA NIH HHS R01 AG026647NIA NIH HHS R37 AG026647NIA NIH HHS T32 AG000260NIDDK NIH HHS DK785483NIGMS NIH HHS GM038109NIGMS NIH HHS GM081192NIGMS NIH HHS GM42336NIGMS NIH HHS R01 GM033301NIGMS NIH HHS R01 GM038109NIGMS NIH HHS R01 GM042336NIGMS NIH HHS R37 GM038109NIMH NIH HHS MH084512NIMH NIH HHS U54 MH084512NINDS NIH HHS NS047331NINDS NIH HHS R01 NS047331
6 · The paper itself

Abstract

Protein homeostasis (proteostasis) is essential for cellular and organismal health. Stress, aging and the chronic expression of misfolded proteins, however, challenge the proteostasis machinery and the vitality of the cell. Enhanced expression of molecular chaperones, regulated by heat shock transcription factor-1 (HSF-1), has been shown to restore proteostasis in a variety of conformational disease models, suggesting this mechanism as a promising therapeutic approach. We describe the results of a screen comprised of ∼900,000 small molecules that identified new classes of small-molecule proteostasis regulators that induce HSF-1-dependent chaperone expression and restore protein folding in multiple conformational disease models. These beneficial effects to proteome stability are mediated by HSF-1, FOXO, Nrf-2 and the chaperone machinery through mechanisms that are distinct from current known small-molecule activators of the heat shock response. We suggest that modulation of the proteostasis network by proteostasis regulators may be a promising therapeutic approach for the treatment of a variety of protein conformational diseases.

Indexed as

Drug Evaluation, PreclinicalAnimalsCaenorhabditis elegansCell LineDNA-Binding ProteinsForkhead Transcription FactorsHeat Shock Transcription FactorsHomeostasisHumansMolecular ChaperonesNF-E2-Related Factor 2Protein ConformationProteinsProteostasis DeficienciesRatsTranscription FactorsDNA-Binding ProteinsForkhead Transcription FactorsHeat Shock Transcription FactorsHSF1 protein, humanHsf1 protein, ratMolecular ChaperonesNFE2L2 protein, humanNF-E2-Related Factor 2ProteinsTranscription Factors

Identifiers

PMID22198733
PMCPMC3262058
OpenAlexW2061062422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.